VIP (Vasoactive Intestinal Peptide /PHI and Related Peptides)

Normal Plasma Peptide/Protein Levels

Catalog #	064-21
Standard Size	200 µg
Sequence	Lys - Pro - Arg - Arg - Pro - Tyr - Thr - Asp - Asn - Tyr - Thr - Arg - Leu - Arg - Lys - Gln - Met - Ala - Val - Lys - Lys - Tyr - Leu - Asn - Ser - Ile - Leu - Asn - NH2
M.W	3464.91
Mass Spec Analysis	Exhibits correct M.W.
Solubility	Before reconstitution, please allow 25 to 45 minutes for the lyophilized peptide to return to room temperature. Briefly vortex the Eppendorf tube to concentrate all material at the bottom of the tube. Gently open the cap and reconstitute the peptide to the desired concentration by adding a sterile, aqueous solution to the tube. Invert the tube 5 times by hand to ensure a homogeneous solution.
Storage Condition	Store peptide in DRY form at 0-5°C.
Appearance	White powder
Content	The contents of this vial have been accurately determined to contain 200µg of NET peptide.
HPLC Analysis	Purity ≥95%
Additional articles	For best results and reproducibility, rehydrate peptide just before use. Do not refreeze any unused portions. Do not attempt to weigh out smaller portions.

Please click here or click the reference tab on the top to see more articles that use this product.

Link to the publications that use this peptide: 

Moody TW, Dudek J, Zakowicz H, et al. VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40T antigen mice.
Life Sci. 2004;74(11):1345-57. 

"Markedly inhibits VIP's effect on sexual behavior and competitively displaces the binding of VIP to glial cells."Gozes et al. Vasoactive intestinal peptide potentiates sexual behavior: inhibition by novel antagonist. Endocrinology. 1989 Dec;125(6):2945-9.

For best results and reproducibility, rehydrate peptide just before use. Do not refreeze any unused portions. Do not attempt to weigh out smaller portions.